Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018134 · ClinicalTrials.gov registry record · Phase 2
Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study
A Phase 2 study, sponsored by Sun Pharmaceutical Industries.
- Completed
- Registry status
- Phase 2
- Development phase
- 151
- Enrollment target
NCT01018134 is a Phase 2 study that has completed, run by Sun Pharmaceutical Industries. The registered enrollment target is 151 participants.
The verdict
NCT01018134, a Phase 2 study, has completed, sponsored by Sun Pharmaceutical Industries.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 151 participants
- Enrollment target
Study Summary
The objectives of this study are to evaluate the efficacy and safety of two dosing regimens of desoximetasone 0.05% and 0.25% topical sprays as compared to a vehicle spray in patients with moderate to severe plaque psoriasis.
Interventions
- DRUG Desoximetasone 0.05% once daily
- DRUG Desoximetasone 0.05% twice daily
- DRUG Desoximetasone 0.25% once daily
- DRUG Vehicle once daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01018134
The ClinicalTrials.gov registry entry for NCT01018134 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sun Pharmaceutical Industries, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Desoximetasone 0.05% once daily is the first listed.
NCT01018134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01018134 about?
NCT01018134 is a clinical study titled "Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study". The objectives of this study are to evaluate the efficacy and safety of two dosing regimens of desoximetasone 0.05% and 0.25% topical sprays as compared to a vehicle spray in patients with moderate to severe plaque psoriasis.
What is the current status of trial NCT01018134?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 151 participants. The study started on 2009-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT01018134?
The interventions under investigation include: Desoximetasone 0.05% once daily (DRUG), Desoximetasone 0.05% twice daily (DRUG), Desoximetasone 0.25% once daily (DRUG), Vehicle once daily (DRUG).
Who is sponsoring clinical trial NCT01018134?
This trial is sponsored by Sun Pharmaceutical Industries, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.